Search results
New COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 11 hours agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
Why it's so challenging to develop vaccines for parasitic diseases
BBC News· 23 hours agoThe process of making vaccines for parasites is extremely challenging – but scientists might be on...
Anthony Fauci Name-Checks Rep. Marjorie Taylor Greene As A Driver Of Death Threats
HuffPost via Yahoo News· 20 hours agoGreene, a vaccine conspiracy theorist, sparked fireworks at the hearing with her antics, including...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 2 days agoThe current predominant strain of COVID-19 should be a key consideration during the upcoming meeting...
Study: High excess death rates in the West for 3 years running since start of pandemic despite...
Medical Xpress· 1 day agoExcess death rates have remained high in the West for three years running since the start of the COVID-19 pandemic, finds a data analysis of 47 countries published in BMJ Public Health. This ...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 2 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest...
Rising mosquito populations bring West Nile Virus concerns to North Dakota
Valley News Live· 8 hours agoResidents are urged to take preventive measures.
FDA approves Moderna's RSV vaccine, its second marketed product
USA Today· 5 days agoThe U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus vaccine,...
What should you do if you’re still testing positive for COVID-19 after day 10?
The Today Show via AOL· 8 hours agoThe virus poses particularly serious risks for certain populations, including immunocompromised...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 2 days agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...